Latest News

EVN's Q1 2026 results in focus EVN (WBAG:EVN) opened its 2026 financial year with Q1 revenue of €874.4 million and basic EPS of €0.69, setting a clear marker for how the year is starting to shape up. The company has seen quarterly revenue move from €804.1 million in Q1 2025 to €874.4 million in Q1 2026, while basic EPS in the same first quarter comparison went from €0.62 to €0.69, against a trailing twelve month EPS figure of €2.63 on revenue of €3.1b. With net profit margin sitting at 15.3%...

Earlier this week, Canadian Imperial Bank of Commerce reported first-quarter 2026 results showing higher net interest income of C$4,308 million and net income of C$3,093 million, alongside a quarterly common share dividend of C$1.07 and multiple new fixed-income note issuances across maturities from 2029 to 2041. The combination of stronger earnings, an affirmed common dividend, and an active program of senior unsecured bond offerings underlines CIBC’s use of both equity and debt markets to...

EMCOR Group (EME) closed out FY 2025 with fourth quarter revenue of US$4.5b and basic EPS of US$9.72, alongside net income excluding extra items of US$434.6m, setting a clear marker for its latest reporting season. The company reported quarterly revenue of US$3.8b and EPS of US$6.35 in Q4 2024, rising to US$4.5b and EPS of US$9.72 in Q4 2025. Trailing twelve month EPS was US$28.30 on revenue of US$17.0b, giving investors a results set that combines higher earnings, a 7.5% net margin and prior...

On 23 February 2026, Fosun International received the "Certificate of Excellence in Environmental, Social and Governance Reporting" from the Hong Kong Management Association, recognizing its ESG reporting quality and climate-related disclosure efforts. This award underlines how Fosun’s “Create IMPACT” sustainable development strategy has embedded transparency, climate action, and governance into its core business approach. We’ll now examine how Fosun’s strengthened ESG reporting and climate...

Capgemini (ENXTPA:CAP) has just signed new deals with Deutsche Telekom and TELUS to advance network automation, alongside a partnership with OpenAI, which puts telecom and AI execution at the center of the stock story. See our latest analysis for Capgemini. Despite the fresh telecom and AI agreements, Capgemini’s recent share price performance has been weak, with a 30 day share price return of 18.67% and a year to date share price return decline of 24.01%. This has contributed to a 1 year...

Marimaca Copper (TSX:MARI) has just completed follow on equity offerings in Canada and Australia, raising about C$256.99 million and A$157.33 million through new common shares and CHESS depositary interests. See our latest analysis for Marimaca Copper. At a recent share price of CA$10.20, Marimaca Copper’s 1 year total shareholder return of 83.78% and 3 year total shareholder return of 188.14% contrast with a 30 day share price return of 12.07% and year to date share price return of 9.89%...

In February 2026, Downer EDI Limited reported half-year results showing lower revenue of A$4,860.7 million but higher net income of A$93.4 million, lifted its fully franked interim dividend to A$0.129 per share, confirmed FY26 NPATA guidance of A$295–315 million, and completed an on-market buy-back of 8,430,236 shares. Together with Macquarie Group ceasing to be a substantial shareholder, these capital management moves signal a renewed focus on earnings quality, shareholder distributions and...

Intro TG Therapeutics (TGTX) just closed out FY 2025 with Q4 revenue of US$192.6 million and basic EPS of US$0.16, alongside trailing twelve month revenue of US$616.3 million and EPS of US$3.10. Over the past couple of years, the company has reported revenue increasing from US$83.9 million in Q3 2024 to US$192.6 million in Q4 2025. Quarterly basic EPS has ranged from US$0.03 in Q1 2025 to US$2.69 in Q3 2025 and US$0.16 in the latest quarter, framing this release as a check-in on how durable...

Erste Group Bank (WBAG:EBS) has wrapped up FY 2025 with fourth quarter revenue of €2.9b and basic EPS of €2.58, while trailing twelve month figures show revenue of €11.2b and EPS of €9.04, framing a solid earnings year. The bank has seen quarterly revenue range from €2.72b in Q1 2025 to €2.9b in Q4, with basic EPS moving between €1.80 and €2.58 over the same period. This gives investors a clear view of consistent top line and bottom line delivery. With trailing net income of €3.5b and a net...

Discovery Silver Corp. recently reported fourth-quarter 2025 sales of US$274.24 million and net income of US$65.29 million, alongside full-year 2025 sales of US$653.21 million and net income of US$106.81 million, and has since added veteran mining auditor Lee Hodgkinson to its board. The company also outlined 2026 gold production guidance of 260,000 to 300,000 ounces and is showcasing this progress at the 35th BMO Global Metals, Mining & Critical Minerals Conference in Hollywood,...

Roche Holding (SWX:ROG) received FDA acceptance of its New Drug Application for giredestrant in advanced breast cancer. The filing seeks approval for giredestrant in combination therapy for patients with metastatic breast cancer previously treated with CDK4/6 inhibitors. Roche reported positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, a rare kidney disease. Roche, a global pharmaceuticals and diagnostics group, is closely watched for its late stage pipeline...

Syndax Pharmaceuticals (SNDX) just reported Q4 2025 results that paired revenue ahead of expectations with a wider loss, as Revuforj net revenue grew 38% and Niktimvo sales continued to build. See our latest analysis for Syndax Pharmaceuticals. At a share price of US$20.67, Syndax has seen a 4.29% 90 day share price return and a 35.27% total shareholder return over the past year, suggesting momentum has been building despite some recent short term softness. If this update on a cancer focused...

PROG Holdings (NYSE:PRG) announced a 7.7% increase in its quarterly dividend, signaling confidence in returning cash to shareholders. The company is managing revenue pressure tied to a weaker retail backdrop and the bankruptcy of a major partner. Management has tightened Progressive Leasing criteria and is leaning more on its buy now, pay later platform and recent acquisitions. PROG Holdings enters this phase of corporate change with its shares at $36.83 and a mixed return profile. The...

AeroVironment (AVAV) drew fresh investor focus after securing a US$186 million delivery order from the U.S. Army for its next-generation Switchblade 600 Block 2 and 300 Block 20 loitering munitions. See our latest analysis for AeroVironment. Despite the new Army order and recent headlines around the BlueHalo acquisition and the CFO transition, AeroVironment’s 30 day share price return of 16.14% and 90 day return of 7.10% contrast with a 1 year total shareholder return of 70.96% and a roughly...

Franklin Resources (BEN) has been back on investors’ radar after its latest quarterly report showed earnings per share coming in ahead of analyst expectations. This has prompted fresh interest in how the asset manager is currently valued. See our latest analysis for Franklin Resources. The recent earnings surprise has come alongside a clear shift in sentiment around the share price, with Franklin Resources posting a 21.43% 90 day share price return and a 46.49% 1 year total shareholder...

KION GROUP (XTRA:KGX) has released its FY 2025 numbers with Q4 revenue of about €3.1b and basic EPS of €0.53, setting the tone for a year where trailing twelve month revenue came in at €11.3b and EPS at €1.76. Over recent quarters the company has seen revenue move from €3.07b in Q4 2024 to €3.10b in Q4 2025, while quarterly EPS shifted from €0.84 to €0.53, against a backdrop of FY 2025 quarterly EPS ranging between a loss of €0.36 in Q1 and €0.87 in Q3. With trailing net profit margins at 2%...

Why Louisiana-Pacific Is On Investors’ Radar Today Louisiana-Pacific (LPX) is drawing attention after recent share moves, with the stock up about 1.4% over the past day but showing mixed performance over the past week and month. See our latest analysis for Louisiana-Pacific. The 1-day share price return of 1.45% comes after a softer patch. The 30-day share price return of 5.10% and 1-year total shareholder return decline of 14.97% signal that shorter term momentum has cooled, despite stronger...

Thermo Fisher Scientific (NYSE:TMO) has launched its TacroType Pharmacogenetic Test for transplant patients. The test is designed to help clinicians personalize tacrolimus dosing using a patient’s genetic profile. This product aims to support more tailored transplant care and potentially improve post transplant management. Thermo Fisher Scientific enters this launch with its shares at $520.12 and a value score of 4, along with mixed recent returns. The stock is up 1.0% over the past week,...

If you are wondering whether Cardinal Infrastructure Group is priced attractively today, you are not alone. The stock has been on many investors' watchlists as questions around its fair value grow louder. The share price sits at US$33.05, with returns of 2.5% over the last 7 days, 19.2% over the past 30 days, and 46.1% year to date. This has sharpened interest in what is actually built into the current valuation. Recent coverage has focused on Cardinal Infrastructure Group's role in the...

Recent performance snapshot for Waste Connections With no single headline event driving attention to Waste Connections (WCN) today, investors may be focusing on how the stock’s recent returns compare with its longer term track record and current business scale. The share price is roughly flat over the past month and shows a return of about 4% decline over the past 3 months, while year to date performance reflects about 3% decline. Over 1 year, total return stands near 8% decline, set against...

If you are wondering whether Crocs at around US$92.70 is a bargain or a trap, you are not alone. The stock has attracted a lot of attention from investors trying to work out what a fair price looks like. Recently, Crocs has had mixed share price returns, with a 3.9% decline over the last 7 days, a 10.2% gain over the last 30 days, a 6.6% gain year to date, an 8.1% decline over 1 year, a 26.0% decline over 3 years, and a 23.3% gain over 5 years. These moves have played out alongside ongoing...

Arcus Biosciences (RCUS) has wrapped up FY 2025 with fourth quarter revenue of US$33 million and a basic EPS loss of US$0.89, alongside a net loss of US$106 million. This sets a clear backdrop of solid top line contributions paired with continued negative earnings. The company has reported quarterly revenue of US$26 million in Q4 2024, US$28 million in Q1 2025, US$160 million in Q2 2025, US$26 million in Q3 2025 and US$33 million in Q4 2025, while EPS has remained in loss territory across...

NCR Voyix (VYX) has just paired a profitable fourth quarter with fresh 2026 guidance and a new 7-Eleven Philippines win, giving investors a clearer view of its software led platform push. See our latest analysis for NCR Voyix. Despite the new 7-Eleven Philippines contract, a buyback authorization increase to US$300 million and 2026 guidance, NCR Voyix’s recent momentum has been weak. Its latest 1-year total shareholder return of 26.95% decline and 5-year total shareholder return of 62.23%...

Carrefour (ENXTPA:CA) posts FY 2025 results with weak first half but steadier trailing earnings picture Carrefour (ENXTPA:CA) has reported its FY 2025 numbers with a soft first half, booking €42.7b in revenue and a basic EPS loss of €0.56, while trailing twelve month figures point to revenue of €83.8b and EPS of €1.43. The company has seen first half revenue move from €41.4b with EPS of €0.04 in 2024 to €42.7b with an EPS loss in 2025, against a backdrop of trailing net profit margin sitting...